Analyst Ratings for Paratek Pharmaceuticals (PRTK) [Buys]
PRTK Rating Summary
PRTK Price Target Summary
- Highest: $20.00 (H.C. Wainwright)
- Lowest: $9.00 (Jefferies)
- Average: $13.33
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$13.33 (+544.1%)
* Over Last 12-Mos
Rating Score: 9.2 / 10
Percentile Rank: 90%
Avg. $ Target:
$13.33 (+544.1%)
* Over Last 12-Mos
Rating Score: 9.2 / 10
Percentile Rank: 90%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/10/2022 | WBB Securities | Steve Brozak | Upgrade | Strong Buy (Speculative Buy) |
11.00 (N/A) |
3.97 (2.07) |
-47.86% | Details |
| 3/2/2021 | Jefferies » Updated 1/24/2023 |
Eun Yang | New Coverage | Buy (N/A) |
9.00 (11.00) |
7.48 (2.07) |
-72.33% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
PRTK Ratings News
- H.C. Wainwright Reiterates Buy Rating, $20 on Paratek Pharmaceuticals (PRTK) on NUZYRA's Fast-Track Designation
- H.C. Wainwright Reiterates Buy Rating on Paratek Pharmaceuticals (PRTK), Cites Impressive Preclinical Results in MAC Lung Infections
- WBB Securities Upgrades Paratek Pharmaceuticals (PRTK) to Strong Buy
- See More
